We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Availability of Primaquine Phosphate From Centers for Disease Control.
- Abstract
Relates the notification issued by the Winthrop Pharmaceuticals to the U.S. Centers for Disease Control regarding the availability of the antimalarila drug primaquine phosphate. Reason for the discontinuance of the drug's production; Expected time frame in which the drug will be commercially available again; Contact information provided for physicians who wish to receive therapeutic courses of primaquine for their patients.
- Subjects
UNITED States; WINTHROP Pharmaceuticals Inc.; PRIMAQUINE; ANTIMALARIALS; ANTIPARASITIC agents; DRUGS
- Publication
JAMA: Journal of the American Medical Association, 1990, Vol 264, Issue 8, p953
- ISSN
0098-7484
- Publication type
Article
- DOI
10.1001/jama.1990.03450080039009